Drawing for FANTTEST

USPTO serial 79357956

FANTTEST

Reviewed by CopyMark Law Group

Reg. 7369623Status 700Registered
Filing date
Status date
Registration date
Apr 30, 2024
Examiner
HARMON, RAYMOND E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with FANTTEST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents for medical purposes; diagnostic preparations for medical purposes; biological preparations for medical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; enzyme preparations for medical purposes; chemical preparations for the diagnosis of pregnancy; reagent paper for medical purposes; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; reagents for use in medical genetic testing for medical gene detection; medicines for human purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medicine cases, portable, filled with pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; disinfectants for hygiene purposes; disinfectant wipes; haemostatic pencils; cotton swabs for medical purposes; tincture of iodine; medicinal alcoholACTIVE
010Testing apparatus for medical purposes, namely, medical diagnostic apparatus for testing for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical apparatus and instruments for diagnostic use, namely, apparatus and instruments for medical diagnostic testing in the fields of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; protective clothing for medical purposes, namely, clothing especially for operating rooms, surgical scrub tops, pants, and hats, protective face masks for medical use; sanitary masks; respirators for filtering air for medical purposes; thermometers for medical purposes; gloves for medical purposes; syringes for medical purposes; blood pressure monitors; incontinence bed pads, namely, mattress for incontinence of urine and feces; belts for medical purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 4, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 4, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 4, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 4, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 30, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 30, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 14, 2024GPNXNOTIFICATION PROCESSED BY IB
Feb 13, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 24, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 24, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 24, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 10, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 10, 2024XAECEXAMINER'S AMENDMENT ENTERED
Jan 10, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 10, 2024GNEAEXAMINERS AMENDMENT E-MAILED
Jan 10, 2024CNEAEXAMINERS AMENDMENT -WRITTEN
Dec 9, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 8, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 17, 2023RFNTREFUSAL PROCESSED BY IB
Sep 25, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2023RFRRREFUSAL PROCESSED BY MPU
Sep 7, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 6, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2023DOCKASSIGNED TO EXAMINER
Dec 23, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Dec 19, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance